ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,187.67
      0.00%
      US Tech 100
      17,568.80
      -0.19%
      Dow Jones
      39,056.39
      0.44%
      Brent Oil
      84.005
      0.53%
      Bitcoin
      60,919.02
      -0.44%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Kinnate Biopharma Inc (KNTE)

      7. Kinnate Biopharma Inc (KNTE) News

      KNTE Kinnate Biopharma Inc

      2.65
      0.00 (0.00%)
      Pre Market
      Last Updated: 20:00:00
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Kinnate Biopharma Inc KNTE NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.00 0.00% 2.65 20:00:00
      Open Price Low Price High Price Close Price Prev Close
      2.65
      more quote information »

      Recent News

      Date Time Source Heading
      5/08/20249:05IHNWFeaturedElement79 Gold Corp Successfully Closes Maverick Springs Option Agreement
      4/03/202409:00GLOBEXOMA Corporation Announces Closing of Tender Offer
      3/19/202416:05GLOBEXOMA Announces Calculation of Additional Price Per Share and..
      3/05/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/05/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/04/202417:27EDGAR2Form SC 14D9 - Solicitation, recommendation statements
      3/01/202408:53EDGAR2Form SC14D9C - Written communication relating to third party..
      3/01/202408:50EDGAR2Form 8-K - Current report
      3/01/202408:35PRNUSKinnate Biopharma Inc. Sells Its Investigational Pan-RAF..
      3/01/202408:30GLOBEKinnate Biopharma Inc. Sells Its Investigational Pan-RAF..
      2/21/202406:01EDGAR2Form SC14D9C - Written communication relating to third party..
      2/16/202417:57PRNUSALERT: Rowley Law PLLC is Investigating Proposed Acquisition..
      2/16/202410:46PRNUSKuehn Law Encourages KNTE, FANG, HAYN, and VINE Investors to..
      2/16/202409:10EDGAR2Form 8-K - Current report
      2/16/202408:00GLOBEXOMA Enters into Agreement to Acquire Kinnate Biopharma for..
      2/14/202409:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      1/16/202416:05EDGAR2Form 8-K - Current report
      12/05/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/05/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/15/202309:00EDGAR2Form 8-K - Current report
      11/09/202316:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      11/09/202316:14EDGAR2Form 8-K - Current report
      11/09/202316:05GLOBEKinnate Biopharma Inc. Reports Third Quarter 2023 Financial..
      9/18/202316:28EDGAR2Form 8-K - Current report
      9/18/202316:10GLOBEKinnate Biopharma Inc. Announces Pipeline Updates, Strategic..
      9/06/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/06/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/08/202316:48EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      8/08/202316:16EDGAR2Form 8-K - Current report
      8/08/202316:05GLOBEKinnate Biopharma Inc. Reports Second Quarter 2023 Financial..
      7/28/202316:06EDGAR2Form 8-K - Current report
      6/01/202316:05GLOBEKinnate Biopharma Inc. to Participate in Upcoming Investor..
      5/11/202316:05GLOBEKinnate Biopharma Inc. Reports First Quarter 2023 Financial..

      Your Recent History

      NASDAQ
      KNTE
      Kinnate Biopharma
      Delayed Upgrade Clock